SRTA

#2886
Strata Critical Medical, Inc. - Class A Common Stock
5.9 7 USD
-0.03%
Market Price
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
5.97
5.97
Range Annuel
3.85
6.50
Changement quotidien
-3.24%
Changement Mensuel
+16.83%
Evolution sur 6 mois
+42.14%
Changement Annuel
+38.19%
Clôture Précédente
6.1 7
Open
5.9 7
Low
5.9 7
High
5.9 7
Volume
62
Afficher le graphique complet

Financials

Aperçu Relevé Statistiques Documents

2026

Current report, Q3 FY2026
Strata Critical Medical, Inc. current report, Q3 FY2026
8-K
Quarterly report, Q2 FY2026
Strata Critical Medical, Inc. quarterly report, Q2 FY2026
10-Q
Current report, Q2 FY2026
Strata Critical Medical, Inc. current report, Q2 FY2026
8-K
Current report, Q2 FY2026
Strata Critical Medical, Inc. current report, Q2 FY2026
8-K
Quarterly report, Q1 FY2026
Strata Critical Medical, Inc. quarterly report, Q1 FY2026
10-Q
Current report, Q1 FY2026
Strata Critical Medical, Inc. current report, Q1 FY2026
8-K
Current report, Q1 FY2026
Strata Critical Medical, Inc. current report, Q1 FY2026
8-K

2025

Annual report, FY2025
Strata Critical Medical, Inc. annual report, FY2025
10-K
Current report, Q4 FY2025
Strata Critical Medical, Inc. current report, Q4 FY2025
8-K
Current report, Q4 FY2025
Strata Critical Medical, Inc. current report, Q4 FY2025
8-K

Strata Critical Medical, Inc. current report, Q4 FY2019

Full document

SEC Filing Summary: Experience Investment Corp. (EXPC)

Business Context and Reporting Period

This Form 8-K was filed by Experience Investment Corp. on October 30, 2019. The registrant is a Delaware corporation and an emerging growth company. The filing reports on the commencement of separate trading for components of its Units following its initial public offering (IPO).

Key Financial Metrics

The filing references the IPO consummated in September 2019, which generated the following capital:

  • Total Units Sold: 27,500,000 (including 2,500,000 from partial over-allotment exercise).
  • Offering Price: $10.00 per Unit.
  • Gross Proceeds: $275,000,000.
  • Warrant Exercise Price: $11.50 per share.

Note: This filing does not provide data on revenue, profit, cash flow, operating margins, debt, or liquidity positions as it is a current report regarding a corporate event rather than a periodic financial statement.

Material Changes

The primary material event reported is the separation of Units into their constituent parts:

  • Separate Trading Commencement: November 1, 2019.
  • Trading Symbols:
    • Units (if not separated): EXPCU
    • Class A Common Stock: EXPC
    • Warrants: EXPCW
  • Structure: Each Unit consists of one share of Class A Common Stock and one-third of one redeemable warrant. No fractional warrants will be issued upon separation.

Guidance, Outlook, and Risks

The filing contains no forward-looking guidance, management commentary on future performance, or specific risk factors beyond the standard mechanics of the separation process. The document notes that holders must contact their brokers to facilitate the separation of Units through the transfer agent, American Stock Transfer & Trust Company.

Investor Verification Checklist

  • Verify the trading status of EXPC and EXPCW on The Nasdaq Capital Market starting November 1, 2019.
  • Confirm the procedure with your broker to separate Units into stock and warrants, noting that fractional warrants are not issued.
  • Review the attached Press Release (Exhibit 99.1) for any additional details on the separation timeline.
  • Check subsequent filings for the company's trust account balance and investment strategy, as this 8-K does not disclose current cash holdings.